SS Innovations International Inc. (NASDAQ: SSII) has supported the launch of Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo, utilizing the SSi Mantra 3.0 surgical robotic system. The program commenced with a robotic-assisted left internal mammary artery (LIMA) takedown, performed by Dr. Sudhir Srivastava, founder and chairman of SS Innovations, alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva. This milestone was highlighted in a recent company video describing the program's introduction.
According to the video, Kings Hospital has completed more than 25 robotic procedures in just three weeks, indicating rapid adoption and early success of the program. This development marks a significant step in expanding access to advanced surgical care in Sri Lanka and underscores the growing global footprint of SS Innovations.
SS Innovations reported 224 cumulative SSi Mantra installations across 12 countries at the end of the second quarter. The company's second-quarter revenue reached $13.9 million, while robotic procedures increased 143% year over year to 2,528. These figures point to rising utilization of the company's installed base, which is critical for recurring revenue and long-term growth in the surgical robotics market.
The next major corporate milestone is regulatory expansion, with SS Innovations pursuing U.S. FDA clearance and European CE marking for the SSi Mantra system. Achieving these certifications would open doors to the world's largest healthcare markets, potentially accelerating adoption and revenue growth.
For industry leaders, this news highlights the increasing globalization of robotic surgery and the competitive landscape. As SS Innovations expands into new geographies and pursues regulatory approvals, it positions itself as a challenger to established players like Intuitive Surgical. The successful launch in Sri Lanka demonstrates the company's ability to execute on its international strategy and could serve as a blueprint for further expansion into emerging markets.
For readers, this development signals broader implications for healthcare access and technological innovation. Robotic-assisted surgery can lead to smaller incisions, reduced pain, and faster recovery times, benefiting patients and healthcare systems. As more hospitals adopt these systems, the demand for trained surgeons and support staff will rise, creating new opportunities in medical education and technology services.
Investors and business leaders should monitor SS Innovations' progress toward FDA and CE mark clearances, as these are pivotal for market expansion. The company's ability to replicate its Sri Lankan success in other regions will be key to its growth trajectory. Additionally, the 143% increase in robotic procedures year over year indicates strong utilization, which is a positive sign for the company's business model and the overall adoption curve of robotic surgery.
For more information on SS Innovations, visit the company's newsroom at https://ibn.fm/SSII.
